From July 1, 2023 to October 9, 2023, the company has repurchased 30,000 shares, representing 0.005243% for CNY 0.49 million. With this, the company has completed the repurchase of 9,865,793 shares, representing 1.7% for CNY 200 million under the buyback announced on October 21, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
20.14 CNY | +1.00% | -3.22% | +3.02% |
Apr. 26 | Sansure Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Feb. 29 | Sansure Biotech's 2023 Profit Drops 81% as Revenue Slumps 84% | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+3.02% | 1.58B | |
-4.67% | 12.33B | |
-5.19% | 8.14B | |
+28.50% | 5.62B | |
-8.09% | 4.24B | |
-55.31% | 3.06B | |
+13.49% | 2.76B | |
-1.34% | 2.41B | |
+32.24% | 2.23B | |
-3.55% | 1.87B |
- Stock Market
- Equities
- 688289 Stock
- News Sansure Biotech Inc.
- Tranche Update on Sansure Biotech Inc.'s Equity Buyback Plan announced on October 21, 2022.